CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 404 enrolled
Drug / intervention
Duloxetine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00408876
NCT00408876Phase 3Completed
CompareCT.gov

Protocol F1J-MC-HMEO Duloxetine Versus Placebo in the Treatment of Chronic Low Back Pain

Eli Lilly and Company·interventional·Posted Dec 7, 2006·Updated Dec 29, 2009

In Brief

A Phase 3 clinical trial evaluating Duloxetine and Placebo for Back Pain Without Radiation. Completed, enrolled 404 participants across 4 sites.

Detailed Summary

The primary purpose of your participation in this study is to help answer the following research question, and not to provide you treatment for your condition--Whether duloxetine once daily can help patients with Chronic Low Back Pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBack Pain Without Radiation
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 7, 2006
Enrollment StartDec 1, 2006
Primary CompletionNov 1, 2007
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 19.6 years ago

Interventions

Duloxetinedrug

Placebodrug